DE69938036D1 - Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe - Google Patents

Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe

Info

Publication number
DE69938036D1
DE69938036D1 DE69938036T DE69938036T DE69938036D1 DE 69938036 D1 DE69938036 D1 DE 69938036D1 DE 69938036 T DE69938036 T DE 69938036T DE 69938036 T DE69938036 T DE 69938036T DE 69938036 D1 DE69938036 D1 DE 69938036D1
Authority
DE
Germany
Prior art keywords
weave
bind
repair
processes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69938036T
Other languages
English (en)
Inventor
Dvm Todd Henderson
Rn Dvm Corson
Tarek Hammad
Medhat Soliman
Louis Lippiello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Application granted granted Critical
Publication of DE69938036D1 publication Critical patent/DE69938036D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Reinforced Plastic Materials (AREA)
  • Inorganic Insulating Materials (AREA)
DE69938036T 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe Expired - Lifetime DE69938036D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7459498P 1998-02-13 1998-02-13
PCT/US1999/003019 WO1999040926A1 (en) 1998-02-13 1999-02-12 Agents and methods for protection, treatment and repair of connective tissue

Publications (1)

Publication Number Publication Date
DE69938036D1 true DE69938036D1 (de) 2008-03-13

Family

ID=22120420

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69941966T Expired - Lifetime DE69941966D1 (de) 1998-02-13 1999-02-12 Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
DE69938036T Expired - Lifetime DE69938036D1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69941966T Expired - Lifetime DE69941966D1 (de) 1998-02-13 1999-02-12 Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe

Country Status (12)

Country Link
EP (2) EP1917966B1 (de)
JP (1) JP2002502881A (de)
AT (2) ATE455548T1 (de)
AU (1) AU764431B2 (de)
CA (1) CA2320202C (de)
CY (1) CY1108110T1 (de)
DE (2) DE69941966D1 (de)
DK (2) DK1053000T3 (de)
ES (2) ES2338946T3 (de)
HK (1) HK1120211A1 (de)
PT (2) PT1053000E (de)
WO (1) WO1999040926A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
DE20004010U1 (de) 2000-03-02 2000-06-21 Febena Pharma GmbH, 50825 Köln Diätische Zusammensetzung mit einem Gehalt an Glycosaminoglycanen
DE10054257A1 (de) * 2000-11-02 2002-05-16 Kief Horst Heilmittel zur Intraarticulären Injektion
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
MX2007011931A (es) * 2007-09-26 2009-03-26 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartritis y enfermedades relacionadas.
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US11000533B2 (en) 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
NZ616660A (en) * 2011-03-25 2016-05-27 Trackside Technologies Pty Ltd Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
BR112022014911A2 (pt) * 2020-01-29 2022-09-20 Lonza Consumer Health Inc Composição de saúde articular e uso da mesma em mamíferos saudáveis
WO2024018956A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネイン又はその塩に由来する苦味及びコンドロイチン硫酸又はその塩に由来する臭みを抑制する方法
WO2024018955A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネインに由来する苦味及びグルコサミン類化合物に由来する異味を抑制する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
JPS63203628A (ja) * 1987-02-19 1988-08-23 Taiyo Kagaku Co Ltd 動物の乳房炎治療剤
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
JPH09143492A (ja) * 1995-11-17 1997-06-03 Katsumasa Koike 酸化脂質の確認方法及び酸化脂質の生成方法
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico

Also Published As

Publication number Publication date
ATE394108T1 (de) 2008-05-15
HK1120211A1 (en) 2009-03-27
EP1917966B1 (de) 2010-01-20
EP1053000B1 (de) 2008-05-07
PT1053000E (pt) 2008-07-11
ES2302373T3 (es) 2008-07-01
EP1053000A4 (de) 2003-01-29
DE69941966D1 (de) 2010-03-11
WO1999040926A1 (en) 1999-08-19
PT1917966E (pt) 2010-03-17
CA2320202A1 (en) 1999-08-19
EP1053000A1 (de) 2000-11-22
AU2674099A (en) 1999-08-30
CA2320202C (en) 2010-09-14
EP1917966A1 (de) 2008-05-07
ES2338946T3 (es) 2010-05-13
DK1053000T3 (da) 2008-09-01
AU764431B2 (en) 2003-08-21
ATE455548T1 (de) 2010-02-15
DK1917966T3 (da) 2010-03-15
JP2002502881A (ja) 2002-01-29
CY1108110T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
DE69429369D1 (de) Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen
ATE284210T1 (de) Verfahren und zusammensetzung zur behandlung von krebs
ATE271385T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
ATE211135T1 (de) Aminocyclohexylester und ihre anwendung
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
DE60009665D1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE69415515D1 (de) Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
DE69429806D1 (de) Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
ATE254128T1 (de) Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69535366D1 (de) Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt
ATE292962T1 (de) Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
DE60000658D1 (de) Zusammensetzung zur behandlung von psoriasis
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Legal Events

Date Code Title Description
8372 Publication of ep patent withdrawn